Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IDEAYA Biosciences (IDYA) Short-term Investments (2019 - 2025)

Historic Short-term Investments for IDEAYA Biosciences (IDYA) over the last 7 years, with Q4 2025 value amounting to $526.6 million.

  • IDEAYA Biosciences' Short-term Investments fell 1104.47% to $526.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $526.6 million, marking a year-over-year decrease of 1104.47%. This contributed to the annual value of $526.6 million for FY2025, which is 1104.47% down from last year.
  • IDEAYA Biosciences' Short-term Investments amounted to $526.6 million in Q4 2025, which was down 1104.47% from $488.0 million recorded in Q3 2025.
  • IDEAYA Biosciences' 5-year Short-term Investments high stood at $591.9 million for Q4 2024, and its period low was $154.7 million during Q4 2021.
  • Over the past 5 years, IDEAYA Biosciences' median Short-term Investments value was $342.5 million (recorded in 2023), while the average stood at $367.9 million.
  • Within the past 5 years, the most significant YoY rise in IDEAYA Biosciences' Short-term Investments was 70341.48% (2021), while the steepest drop was 2686.1% (2021).
  • Quarter analysis of 5 years shows IDEAYA Biosciences' Short-term Investments stood at $154.7 million in 2021, then skyrocketed by 91.44% to $296.2 million in 2022, then increased by 24.27% to $368.1 million in 2023, then surged by 60.81% to $591.9 million in 2024, then dropped by 11.04% to $526.6 million in 2025.
  • Its Short-term Investments was $526.6 million in Q4 2025, compared to $488.0 million in Q3 2025 and $555.1 million in Q2 2025.